Site Menu

ITL BioMedical Expands Safety SubCulture Unit (SCU) Product Line with New SCU Wide Cap Sampler

by Editorial Team

A Safer, More Flexible Solution for Positive Blood Cultures

RESTON, VA – ITL BioMedical, a global leader in laboratory safety solutions, announces the launch of the SCU Wide Cap Sampler, an addition to its Safety SubCulture Unit (SCU) product family. Designed to enhance safety and workflow efficiency in clinical laboratories and hospitals, the SCU Wide Cap Sampler offers a needle-free solution for positive blood culture sampling, reducing exposure risks for laboratorians and improving operational flexibility.

Advancing Lab Safety and Efficiency

ITL BioMedical’s SCU Wide Cap Sampler is specifically engineered to address the safety and workflow needs of modern laboratories. Key benefits include:

By offering a reliable, cost-effective alternative to exposed needle systems, the SCU Wide Cap Sampler empowers clinical laboratories to maintain the highest safety standards while streamlining microbial testing.

Expanding the Safety SubCulture Line

The launch of the SCU Wide Cap Sampler reinforces ITL BioMedical’s commitment to laboratory safety and innovation. The Safety SubCulture product line includes the Safety SubCulture Unit (SCU) and Safety SubCulture Unit 2 (SCU2), needle-free solutions designed to enhance laboratory safety and efficiency through secure sample transfer. These units reduce the risk of sharps injuries and minimize exposure to potentially hazardous culture discharges.

With a focus on usability, precision, and adaptability, ITL BioMedical’s Safety SubCulture products continue to be essential tools for healthcare professionals managing microbial testing.

Availability

The SCU Wide Cap Sampler is available for purchase online at ITLBioMedical.com. For larger quantities, contact inquiries@itlbiomedical.com or call +1 (703) 435-6700 for a personalized quote.

About ITL BioMedical

ITL BioMedical sets industry standards in the innovative design and production of biological sampling systems and healthcare devices for human and animal use. The company’s patented medical devices focus on safety and process efficiency for end users, their blood donors, and patients in blood collection centers and healthcare markets worldwide. ITL BioMedical is a division of ITL Health Group (ASX:ITD).

For more information or inquiries, visit ITLBioMedical.com.

Media Contact:

John Tonkinson, Ph.D.
Vice President of Global Sales and Marketing
+1 (703) 435-6700
John.Tonkinson@itlbiomedical.com

This page might use cookies if your analytics vendor requires them.